Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications
Titel:
Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications
Auteur:
Moreadith, Randall W. Viegas, Tacey X. Bentley, Michael D. Harris, J. Milton Fang, Zhihao Yoon, Kunsang Dizman, Bekir Weimer, Rebecca Rae, Brendan P. Li, Xiuling Rader, Christoph Standaert, David Olanow, Warren